Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East & Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid Sources
1.5.1.2 Unpaid Sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 HLA typing for transplant industry 3600 synopsis, 2018 - 2032
2.2 Business trends
2.2.1 Technology trends
2.2.2 Product and services trends
2.2.3 Application trends
2.2.4 End-use trends
2.2.5 Regional trends
Chapter 3 HLA Typing for Transplant Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing number of solid organ transplants
3.3.1.2 Technological advancements
3.3.1.3 Increasing geriatric population
3.3.2 Restraints
3.3.2.1 Significant gap between number of organs donated and organs required
3.3.2.2 High cost of molecular tests
3.4 Growth potential analysis
3.4.1 By technology
3.4.2 By product and services
3.4.3 By application
3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Total number of HLA typing test performed annually, by region, 2017-2021 (000’ Units)
3.7 Pricing analysis, 2021
3.8 In-house lab-based HLA typing test v/s kits from diagnostic manufacturer
3.9 Evolution of different HLA typing method
3.9.1 PCR-based testing method
3.9.2 NGS-based testing method
3.10 Regulatory landscape
3.10.1 U.S.
3.10.2 Europe
3.11 Porter's analysis
3.11.1 Bargaining power of buyers
3.11.2 Bargaining power of suppliers
3.11.3 Threat of new entrants
3.11.4 Threat of substitutes
3.11.5 Industry rivalry
3.12 PESTEL analysis
3.12.1 Political
3.12.1 Economic
3.12.1 Social
3.12.1 Technological
3.12.1 Environmental
3.12.2 Legal
Chapter 4 Competition Landscape, 2022
4.1 Introduction
4.2 Company market share analysis, 2022
4.3 Company matrix analysis, 2022
4.4 Strategy dashboard, 2022
Chapter 5 HLA Typing for Transplant Market, By Technology
5.1 Key segment trends
5.2 Non-molecular assays
5.2.1 Market size, by region, 2018-2032 (USD Million)
5.2.2 Serological assays
5.2.2.1 Market size, by region, 2018-2032 (USD Million)
5.2.3 Mixed lymphocyte culture assays
5.2.3.1 Market size, by region, 2018-2032 (USD Million)
5.3 Molecular assays
5.3.1 Market size, by region, 2018-2032 (USD Million)
5.3.2 PCR based molecular assays
5.3.2.1 Market size, by region, 2018-2032 (USD Million)
5.3.3 Sequencing based molecular assays
5.3.3.1 Market size, by region, 2018-2032 (USD Million)
5.3.3.2 Sanger sequencing
5.3.3.2.1 Market size, by region, 2018-2032 (USD Million)
5.3.3.3 Next generation sequencing
5.3.3.3.1 Market size, by region, 2018-2032 (USD Million)
Chapter 6 HLA Typing for Transplant Market, By Product & Services
6.1 Key segment trends
6.2 Instruments
6.2.1 Market size, by region, 2018-2032 (USD Million)
6.3 Reagents and consumables
6.3.1 Market size, by region, 2018-2032 (USD Million)
6.4 Software
6.4.1 Market size, by region, 2018-2032 (USD Million)
6.5 Services
6.5.1 Market size, by region, 2018-2032 (USD Million)
Chapter 7 HLA Typing for Transplant Market, By Application
7.1 Key segment trends
7.2 Diagnostics
7.2.1 Market size, by region, 2018-2032 (USD Million)
7.3 Research
7.3.1 Market size, by region, 2018-2032 (USD Million)
Chapter 8 HLA Typing for Transplant Market, By End-use
8.1 Key segment trends
8.2 Hospitals
8.2.1 Market size, by region, 2018-2032 (USD Million)
8.3 Diagnostic labs
8.3.1 Market size, by region, 2018-2032 (USD Million)
8.4 Academic and research institutes centers
8.4.1 Market size, by region, 2018-2032 (USD Million)
Chapter 9 HLA Typing for Transplant Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 Market size, by country, 2018-2032 (USD Million)
9.2.2 Market size, by technology, 2018-2032 (USD Million)
9.2.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.2.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.2.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.2.3 Market size, by product and services, 2018-2032 (USD Million)
9.2.4 Market size, by application, 2018-2032 (USD Million)
9.2.5 Market size, by end-use, 2018-2032 (USD Million)
9.2.6 U.S.
9.2.6.1 Market size, by technology, 2018-2032 (USD Million)
9.2.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.2.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.2.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.2.6.2 Market size, by product and services, 2018-2032 (USD Million)
9.2.6.3 Market size, by application, 2018-2032 (USD Million)
9.2.6.4 Market size, by end-use, 2018-2032 (USD Million)
9.2.7 Canada
9.2.7.1 Market size, by technology, 2018-2032 (USD Million)
9.2.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.2.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.2.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.2.7.2 Market size, by product and services, 2018-2032 (USD Million)
9.2.7.3 Market size, by application, 2018-2032 (USD Million)
9.2.7.4 Market size, by end-use, 2018-2032 (USD Million)
9.3 Europe
9.3.1 Market size, by country, 2018-2032 (USD Million)
9.3.2 Market size, by technology, 2018-2032 (USD Million)
9.3.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.3 Market size, by product and services, 2018-2032 (USD Million)
9.3.4 Market size, by application, 2018-2032 (USD Million)
9.3.5 Market size, by end-use, 2018-2032 (USD Million)
9.3.6 Germany
9.3.6.1 Market size, by technology, 2018-2032 (USD Million)
9.3.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.6.2 Market size, by product and services, 2018-2032 (USD Million)
9.3.6.3 Market size, by application, 2018-2032 (USD Million)
9.3.6.4 Market size, by end-use, 2018-2032 (USD Million)
9.3.7 UK
9.3.7.1 Market size, by technology, 2018-2032 (USD Million)
9.3.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.7.2 Market size, by product and services, 2018-2032 (USD Million)
9.3.7.3 Market size, by application, 2018-2032 (USD Million)
9.3.7.4 Market size, by end-use, 2018-2032 (USD Million)
9.3.8 France
9.3.8.1 Market size, by technology, 2018-2032 (USD Million)
9.3.8.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.8.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.8.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.8.2 Market size, by product and services, 2018-2032 (USD Million)
9.3.8.3 Market size, by application, 2018-2032 (USD Million)
9.3.8.4 Market size, by end-use, 2018-2032 (USD Million)
9.3.9 Italy
9.3.9.1 Market size, by technology, 2018-2032 (USD Million)
9.3.9.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.9.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.9.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.9.2 Market size, by product and services, 2018-2032 (USD Million)
9.3.9.3 Market size, by application, 2018-2032 (USD Million)
9.3.9.4 Market size, by end-use, 2018-2032 (USD Million)
9.3.10 Spain
9.3.10.1 Market size, by technology, 2018-2032 (USD Million)
9.3.10.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.10.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.10.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.10.2 Market size, by product and services, 2018-2032 (USD Million)
9.3.10.3 Market size, by application, 2018-2032 (USD Million)
9.3.10.4 Market size, by end-use, 2018-2032 (USD Million)
9.3.11 Russia
9.3.11.1 Market size, by technology, 2018-2032 (USD Million)
9.3.11.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.3.11.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.3.11.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.3.11.2 Market size, by product and services, 2018-2032 (USD Million)
9.3.11.3 Market size, by application, 2018-2032 (USD Million)
9.3.11.4 Market size, by end-use, 2018-2032 (USD Million)
9.4 Asia Pacific
9.4.1 Market size, by country, 2018-2032 (USD Million)
9.4.2 Market size, by technology, 2018-2032 (USD Million)
9.4.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.4.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.4.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.4.3 Market size, by product and services, 2018-2032 (USD Million)
9.4.4 Market size, by application, 2018-2032 (USD Million)
9.4.5 Market size, by end-use, 2018-2032 (USD Million)
9.4.6 China
9.4.6.1 Market size, by technology, 2018-2032 (USD Million)
9.4.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.4.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.4.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.4.6.2 Market size, by product and services, 2018-2032 (USD Million)
9.4.6.3 Market size, by application, 2018-2032 (USD Million)
9.4.6.4 Market size, by end-use, 2018-2032 (USD Million)
9.4.7 India
9.4.7.1 Market size, by technology, 2018-2032 (USD Million)
9.4.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.4.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.4.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.4.7.2 Market size, by product and services, 2018-2032 (USD Million)
9.4.7.3 Market size, by application, 2018-2032 (USD Million)
9.4.7.4 Market size, by end-use, 2018-2032 (USD Million)
9.4.8 Japan
9.4.8.1 Market size, by technology, 2018-2032 (USD Million)
9.4.8.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.4.8.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.4.8.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.4.8.2 Market size, by product and services, 2018-2032 (USD Million)
9.4.8.3 Market size, by application, 2018-2032 (USD Million)
9.4.8.4 Market size, by end-use, 2018-2032 (USD Million)
9.4.9 Australia
9.4.9.1 Market size, by technology, 2018-2032 (USD Million)
9.4.9.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.4.9.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.4.9.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.4.9.2 Market size, by product and services, 2018-2032 (USD Million)
9.4.9.3 Market size, by application, 2018-2032 (USD Million)
9.4.9.4 Market size, by end-use, 2018-2032 (USD Million)
9.5 Latin America
9.5.1 Market size, by country, 2018-2032 (USD Million)
9.5.2 Market size, by technology, 2018-2032 (USD Million)
9.5.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.5.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.5.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.5.3 Market size, by product and services, 2018-2032 (USD Million)
9.5.4 Market size, by application, 2018-2032 (USD Million)
9.5.5 Market size, by end-use, 2018-2032 (USD Million)
9.5.6 Brazil
9.5.6.1 Market size, by technology, 2018-2032 (USD Million)
9.5.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.5.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.5.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.5.6.2 Market size, by product and services, 2018-2032 (USD Million)
9.5.6.3 Market size, by application, 2018-2032 (USD Million)
9.5.6.4 Market size, by end-use, 2018-2032 (USD Million)
9.5.7 Mexico
9.5.7.1 Market size, by technology, 2018-2032 (USD Million)
9.5.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.5.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.5.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.5.7.2 Market size, by product and services, 2018-2032 (USD Million)
9.5.7.3 Market size, by application, 2018-2032 (USD Million)
9.5.7.4 Market size, by end-use, 2018-2032 (USD Million)
9.6 MEA
9.6.1 Market size, by country, 2018-2032 (USD Million)
9.6.2 Market size, by technology, 2018-2032 (USD Million)
9.6.2.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.6.2.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.6.2.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.6.3 Market size, by product and services, 2018-2032 (USD Million)
9.6.4 Market size, by application, 2018-2032 (USD Million)
9.6.5 Market size, by end-use, 2018-2032 (USD Million)
9.6.6 South Africa
9.6.6.1 Market size, by technology, 2018-2032 (USD Million)
9.6.6.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.6.6.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.6.6.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.6.6.2 Market size, by product and services, 2018-2032 (USD Million)
9.6.6.3 Market size, by application, 2018-2032 (USD Million)
9.6.6.4 Market size, by end-use, 2018-2032 (USD Million)
9.6.7 Saudi Arabia
9.6.7.1 Market size, by technology, 2018-2032 (USD Million)
9.6.7.1.1 Market size, by non-molecular assays, 2018-2032 (USD Million)
9.6.7.1.2 Market size, by molecular assays, 2018-2032 (USD Million)
9.6.7.1.2.1 Market size, by sequencing based molecular assays, 2018-2032 (USD Million)
9.6.7.2 Market size, by product and services, 2018-2032 (USD Million)
9.6.7.3 Market size, by application, 2018-2032 (USD Million)
9.6.7.4 Market size, by end-use, 2018-2032 (USD Million)
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Business overview
10.1.2 Financial data
10.1.3 Product landscape
10.1.4 Strategic outlook
10.1.5 SWOT analysis
10.2 Bio-Rad Laboratories
10.2.1 Business overview
10.2.2 Financial data
10.2.3 Product landscape
10.2.4 Strategic outlook
10.2.5 SWOT analysis
10.3 BioReference Laboratories
10.3.1 Business overview
10.3.2 Financial data
10.3.3 Product landscape
10.3.4 SWOT analysis
10.4 CareDx, Inc.
10.4.1 Business overview
10.4.2 Financial data
10.4.3 Product landscape
10.4.4 Strategic outlook
10.4.5 SWOT analysis
10.5 GenDx
10.5.1 Business overview
10.5.2 Financial data
10.5.3 Product landscape
10.5.4 Strategic outlook
10.5.5 SWOT analysis
10.6 Illumina Inc.
10.6.1 Business overview
10.6.2 Financial data
10.6.3 Product landscape
10.6.4 Strategic outlook
10.6.5 SWOT analysis
10.7 Immucor Inc.
10.7.1 Business overview
10.7.2 Financial data
10.7.3 Product landscape
10.7.4 Strategic outlook
10.7.5 SWOT analysis
10.8 Inno-train Diagnostik GmbH
10.8.1 Business overview
10.8.2 Financial data
10.8.3 Product landscape
10.8.4 SWOT analysis
10.9 Luminex Corporation
10.9.1 Business overview
10.9.2 Financial data
10.9.3 Product landscape
10.9.4 SWOT analysis
10.10 Omixon, Inc
10.10.1 Business overview
10.10.2 Financial data
10.10.3 Product landscape
10.10.4 Strategic outlook
10.10.5 SWOT analysis
10.11 Pacific Biosciences of California, Inc
10.11.1 Business overview
10.11.2 Financial data
10.11.3 Product landscape
10.11.4 Strategic outlook
10.11.5 SWOT analysis
10.12 Qiagen N.V.
10.12.1 Business overview
10.12.2 Financial data
10.12.3 Product landscape
10.12.4 SWOT analysis
10.13 F. Hoffmann-La Roche Ltd
10.13.1 Business overview
10.13.2 Financial data
10.13.3 Product landscape
10.13.4 SWOT analysis
10.14 Thermo-Fisher Scientific Inc.
10.14.1 Business overview
10.14.2 Financial data
10.14.3 Product landscape
10.14.4 Strategic outlook
10.14.5 SWOT analysis
10.15 Fujirebio
10.15.1 Business overview
10.15.2 Financial data
10.15.3 Product landscape
10.15.4 SWOT analysis
10.16 BAG Diagnostic GmbH
10.16.1 Business overview
10.16.2 Financial data
10.16.3 Product landscape
10.16.4 SWOT analysis
10.17 GMSbiotech, Inc.
10.17.1 Business overview
10.17.2 Financial data
10.17.3 Product landscape
10.17.4 SWOT analysis
10.18 Biofortuna Limited
10.18.1 Business overview
10.18.2 Financial data
10.18.3 Product landscape
10.18.4 Strategic outlook
10.18.5 SWOT analysis
10.19 TBG Diagnostics Limited
10.19.1 Business overview
10.19.2 Financial data
10.19.3 Product landscape
10.19.4 Strategic outlook
10.19.5 SWOT analysis
